Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 1994;89:224-227

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Page, R. L.
Right arrow Articles by Pritchett, E. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Page, R. L.
Right arrow Articles by Pritchett, E. L.
Right arrowPubmed/NCBI databases
Medline Plus Health Information
*Atrial Fibrillation

Circulation, Vol 89, 224-227, Copyright © 1994 by American Heart Association


ARTICLES

Asymptomatic arrhythmias in patients with symptomatic paroxysmal atrial fibrillation and paroxysmal supraventricular tachycardia

RL Page, WE Wilkinson, WK Clair, EA McCarthy and EL Pritchett
Department of Medicine, Duke University Medical Center, Durham, NC.

BACKGROUND: Paroxysmal atrial fibrillation and paroxysmal supraventricular tachycardia are recognized clinically when patients seek treatment for symptoms due to recurrent arrhythmias; atrial fibrillation also increases the risk of stroke. The frequency with which asymptomatic arrhythmias occur in patients with these arrhythmias is unknown. METHODS AND RESULTS: Twenty-two patients with paroxysmal atrial fibrillation (n = 8) or paroxysmal supraventricular tachycardia (n = 14) were studied for 29 days with two different ambulatory ECG- monitoring techniques to measure the relative frequency of asymptomatic and symptomatic arrhythmias. All class I antiarrhythmic drugs, calcium channel blockers, beta-blockers, and digitalis were withheld. Sustained asymptomatic arrhythmia events (defined as lasting at least 30 seconds) were documented using continuous ambulatory ECG monitoring once weekly for a total of 5 of the 29 study days; symptomatic arrhythmia events were documented using transtelephonic ECG monitoring for all 29 days of the study. In the group of patients with paroxysmal atrial fibrillation, asymptomatic arrhythmia events occurred significantly more frequently than symptomatic arrhythmia events; the mean rates, expressed as events/100 d/patient (95% confidence interval), were 62.5 (40.4, 87.3) and 5.2 (2.7, 9.0) (P < .01); the ratio of the mean rates was 12.1 (5.8, 26.4). In contrast, in the group of patients with paroxysmal supraventricular tachycardia, asymptomatic arrhythmia events were significantly less frequent than symptomatic arrhythmia events; the mean rates were 0.0 (0.0, 5.3) and 7.4 (5.0, 10.6) (P = .02). The ratio of the mean rates was 0.0 (0.0, 0.8). CONCLUSIONS: In a group of patients with paroxysmal atrial fibrillation, sustained asymptomatic atrial fibrillation occurs far more frequently than symptomatic atrial fibrillation. However, it is not known whether asymptomatic atrial fibrillation is a potential risk factor for stroke even when patients are not having symptomatic arrhythmias.


This article has been cited by other articles:


Home page
EuropaceHome page
G. Kaleschke, B. Hoffmann, I. Drewitz, G. Steinbeck, M. Naebauer, A. Goette, G. Breithardt, and P. Kirchhof
Prospective, multicentre validation of a simple, patient-operated electrocardiographic system for the detection of arrhythmias and electrocardiographic changes
Europace, October 1, 2009; 11(10): 1362 - 1368.
[Abstract] [Full Text] [PDF]


Home page
EuropaceHome page
F. Halimi, L. Van Erven, and on behalf of the EHRA Scientific Initiatives Commi
Validation of success following atrial fibrillation ablation: a European survey
Europace, August 1, 2009; 11(8): 1002 - 1003.
[Abstract] [Full Text] [PDF]


Home page
EuropaceHome page
P. Kirchhof, J. Bax, C. Blomstrom-Lundquist, H. Calkins, A. J. Camm, R. Cappato, F. Cosio, H. Crijns, H.-C. Diener, A. Goette, et al.
Early and comprehensive management of atrial fibrillation: Proceedings from the 2nd AFNET/EHRA consensus conference on atrial fibrillation entitled 'research perspectives in atrial fibrillation'
Europace, July 1, 2009; 11(7): 860 - 885.
[Full Text] [PDF]


Home page
Mayo Clin Proc.Home page
M. A. Crandall, D. J. Bradley, D. L. Packer, and S. J. Asirvatham
Contemporary Management of Atrial Fibrillation: Update on Anticoagulation and Invasive Management Strategies
Mayo Clin. Proc., July 1, 2009; 84(7): 643 - 662.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
P. Kirchhof, J. Bax, C. Blomstrom-Lundquist, H. Calkins, A. John Camm, R. Cappato, F. Cosio, H. Crijns, H.-C. Diener, A. Goette, et al.
Early and comprehensive management of atrial fibrillation: executive summary of the proceedings from the 2nd AFNET-EHRA consensus conference 'research perspectives in AF'
Eur. Heart J., June 17, 2009; (2009) ehp235v1.
[Abstract] [Full Text] [PDF]


Home page
Circ Arrhythm ElectrophysiolHome page
P. Dorian, P. G. Guerra, C. R. Kerr, S. S. O'Donnell, E. Crystal, A. M. Gillis, L. B. Mitchell, D. Roy, A. C. Skanes, M. S. Rose, et al.
Validation of a New Simple Scale to Measure Symptoms in Atrial Fibrillation: The Canadian Cardiovascular Society Severity in Atrial Fibrillation Scale
Circ Arrhythm Electrophysiol, June 1, 2009; 2(3): 218 - 224.
[Abstract] [Full Text] [PDF]


Home page
EuropaceHome page
A. Arya, J. Silberbauer, S. L. Teichman, P. Milner, N. Sulke, and A. J. Camm
A preliminary assessment of the effects of ATI-2042 in subjects with paroxysmal atrial fibrillation using implanted pacemaker methodology
Europace, April 1, 2009; 11(4): 458 - 464.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
D. Kaireviciute, A. Aidietis, and G. Y.H. Lip
Atrial fibrillation following cardiac surgery: clinical features and preventative strategies
Eur. Heart J., February 2, 2009; 30(4): 410 - 425.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart J SupplHome page
A. J. Camm and J. A. Reiffel
Defining endpoints in clinical trials on atrial fibrillation
Eur. Heart J. Suppl., September 1, 2008; 10(suppl_H): H55 - H78.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
D. E. Singer, G. W. Albers, J. E. Dalen, M. C. Fang, A. S. Go, J. L. Halperin, G. Y. H. Lip, and W. J. Manning
Antithrombotic Therapy in Atrial Fibrillation: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition)
Chest, June 1, 2008; 133(6_suppl): 546S - 592S.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
J. T. Nguyen and D. G. Benditt
Atrial Fibrillation Susceptibility in Metabolic Syndrome: Simply the Sum of Its Parts?
Circulation, March 11, 2008; 117(10): 1249 - 1251.
[Full Text] [PDF]


Home page
Eur Heart JHome page
P. Kirchhof, A. Auricchio, J. Bax, H. Crijns, J. Camm, H.-C. Diener, A. Goette, G. Hindricks, S. Hohnloser, L. Kappenberger, et al.
Outcome parameters for trials in atrial fibrillation: executive summary: Recommendations from a consensus conference organized by the German Atrial Fibrillation Competence NETwork (AFNET) and the European Heart Rhythm Association (EHRA)
Eur. Heart J., November 2, 2007; 28(22): 2803 - 2817.
[Abstract] [Full Text] [PDF]


Home page
EuropaceHome page
P. Kirchhof, A. Auricchio, J. Bax, H. Crijns, J. Camm, H.-C. Diener, A. Goette, G. Hindricks, S. Hohnloser, L. Kappenberger, et al.
Outcome parameters for trials in atrial fibrillation: Recommendations from a consensus conference organized by the German Atrial Fibrillation Competence NETwork and the European Heart Rhythm Association
Europace, November 1, 2007; 9(11): 1006 - 1023.
[Abstract] [Full Text] [PDF]


Home page
EuropaceHome page
W. de Voogt, N. van Hemel, P. de Vusser, G. H. Mairesse, R. van Mechelen, J. Koistinen, A. van den Bos, I. Roose, J. Voitk, S. Yli-Mayry, et al.
No evidence of automatic atrial overdrive pacing efficacy on reduction of paroxysmal atrial fibrillation
Europace, September 1, 2007; 9(9): 798 - 804.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
J. R. Mehall, R. M. Kohut Jr, E. W. Schneeberger, W. H. Merrill, and R. K. Wolf
Absence of Correlation Between Symptoms and Rhythm in "Symptomatic" Atrial Fibrillation
Ann. Thorac. Surg., June 1, 2007; 83(6): 2118 - 2121.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
N. F Murphy, C. R Simpson, P. S Jhund, S. Stewart, M. Kirkpatrick, J. Chalmers, K. MacIntyre, and J. J V McMurray
A national survey of the prevalence, incidence, primary care burden and treatment of atrial fibrillation in Scotland
Heart, May 1, 2007; 93(5): 606 - 612.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
D. G. Sherman
Stroke Prevention in Atrial Fibrillation: Pharmacological Rate Versus Rhythm Control
Stroke, February 1, 2007; 38(2): 615 - 617.
[Abstract] [Full Text] [PDF]


Home page
Arch NeurolHome page
A. J. van der Kooi, W. G. de Voogt, E. Bertini, L. Merlini, F. B. Talim, R. Ben Yaou, A. Urtziberea, and M. de Visser
Cardiac and Pulmonary Investigations in Bethlem Myopathy
Arch Neurol, November 1, 2006; 63(11): 1617 - 1621.
[Abstract] [Full Text] [PDF]


Home page
EuropaceHome page
Writing Committee Members, V. Fuster, L. E. Ryden, D. S. Cannom, H. J. Crijns, A. B. Curtis, K. A. Ellenbogen, J. L. Halperin, J.-Y. Le Heuzey, G. N. Kay, et al.
ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: full text: A report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation) Developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society
Europace, September 1, 2006; 8(9): 651 - 745.
[Full Text] [PDF]


Home page
HeartHome page
A Nergardh and M Frick
Perceived heart rhythm in relation to ECG findings after direct current cardioversion of atrial fibrillation
Heart, September 1, 2006; 92(9): 1244 - 1247.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
T R Betts
Rhythm control strategies for "symptomatic" persistent atrial fibrillation: is achieving sinus rhythm enough?
Heart, September 1, 2006; 92(9): 1189 - 1190.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
V. Fuster, L. E. Ryden, D. S. Cannom, H. J. Crijns, A. B. Curtis, K. A. Ellenbogen, J. L. Halperin, J.-Y. Le Heuzey, G. N. Kay, J. E. Lowe, et al.
ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation--Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation) Developed in Collaboration With the European Heart Rhythm Association and the Heart Rhythm Society
J. Am. Coll. Cardiol., August 15, 2006; 48(4): 854 - 906.
[Full Text] [PDF]


Home page
J Am Coll CardiolHome page
V. Fuster, L. E. Ryden, D. S. Cannom, H. J. Crijns, A. B. Curtis, K. A. Ellenbogen, J. L. Halperin, J.-Y. Le Heuzey, G. N. Kay, J. E. Lowe, et al.
ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation) Developed in Collaboration With the European Heart Rhythm Association and the Heart Rhythm Society
J. Am. Coll. Cardiol., August 15, 2006; 48(4): e149 - e246.
[Full Text] [PDF]


Home page
CirculationHome page
V. Fuster, L. E. Ryden, D. S. Cannom, H. J. Crijns, A. B. Curtis, K. A. Ellenbogen, J. L. Halperin, J.-Y. Le Heuzey, G. N. Kay, J. E. Lowe, et al.
ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation): Developed in Collaboration With the European Heart Rhythm Association and the Heart Rhythm Society
Circulation, August 15, 2006; 114(7): e257 - e354.
[Full Text] [PDF]


Home page
CirculationHome page
V. Fuster, L. E. Ryden, D. S. Cannom, H. J. Crijns, A. B. Curtis, K. A. Ellenbogen, J. L. Halperin, J.-Y. Le Heuzey, G. N. Kay, J. E. Lowe, et al.
ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation--Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation): Developed in Collaboration With the European Heart Rhythm Association and the Heart Rhythm Society
Circulation, August 15, 2006; 114(7): 700 - 752.
[Full Text] [PDF]


Home page
Eur Heart JHome page
Authors/Task Force Members, V. Fuster, L. E. Ryden, D. S. Cannom, H. J. Crijns, A. B. Curtis, K. A. Ellenbogen, J. L. Halperin, J.-Y. Le Heuzey, G. N. Kay, et al.
ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation executive summary: A report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients with Atrial Fibrillation) Developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society
Eur. Heart J., August 2, 2006; 27(16): 1979 - 2030.
[Full Text] [PDF]


Home page
EuropaceHome page
T. Neumann, A. Erdogan, T. Dill, H. Greiss, A. Berkowitsch, J. Sperzel, M. Kuniss, K. Kurzidim, C. W. Hamm, and H.-F. Pitschner
Asymptomatic recurrences of atrial fibrillation after pulmonary vein isolation
Europace, July 1, 2006; 8(7): 495 - 498.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
E. Hoffmann, N. Sulke, N. Edvardsson, J. Ruiter, T. Lewalter, A. Capucci, A. Schuchert, S. Janko, J. Camm, and on behalf of the Atrial Fibrillation Therapy (AFT)
New Insights Into the Initiation of Atrial Fibrillation: A Detailed Intraindividual and Interindividual Analysis of the Spontaneous Onset of Atrial Fibrillation Using New Diagnostic Pacemaker Features
Circulation, April 25, 2006; 113(16): 1933 - 1941.
[Abstract] [Full Text] [PDF]


Home page
EuropaceHome page
F. Enseleit and F. Duru
Long-term continuous external electrocardiographic recording: a review.
Europace, April 1, 2006; 8(4): 255 - 266.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
G. Hindricks, C. Piorkowski, H. Tanner, R. Kobza, J.-H. Gerds-Li, C. Carbucicchio, and H. Kottkamp
Perception of Atrial Fibrillation Before and After Radiofrequency Catheter Ablation: Relevance of Asymptomatic Arrhythmia Recurrence
Circulation, July 19, 2005; 112(3): 307 - 313.
[Abstract] [Full Text] [PDF]


Home page
Arch Intern MedHome page
D. G. Sherman, S. G. Kim, B. S. Boop, S. D. Corley, J. P. DiMarco, R. G. Hart, L. J. Haywood, K. Hoyte, E. S. Kaufman, M. H. Kim, et al.
Occurrence and Characteristics of Stroke Events in the Atrial Fibrillation Follow-up Investigation of Sinus Rhythm Management (AFFIRM) Study
Arch Intern Med, May 23, 2005; 165(10): 1185 - 1191.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart J SupplHome page
B. J. Gersh, T. S.M. Tsang, M. E. Barnes, and J. B. Seward
The changing epidemiology of non-valvular atrial fibrillation: the role of novel risk factors
Eur. Heart J. Suppl., May 1, 2005; 7(suppl_C): C5 - C11.
[Abstract] [Full Text] [PDF]


Home page
JAMAHome page
H. S. Bajaj and S. D. Hillson
Obesity and the Risk of New-Onset Atrial Fibrillation
JAMA, April 27, 2005; 293(16): 1974 - 1975.
[Full Text] [PDF]


Home page
NEJMHome page
G. C. Gronefeld, S. H. Hohnloser, S. H. Konety, B. Olshansky, A. K. Wittkowsky, P. Alboni, G. I. Botto, and N. Baldi
The "Pill-in-the-Pocket" Approach to Atrial Fibrillation
N. Engl. J. Med., March 17, 2005; 352(11): 1150 - 1151.
[Full Text] [PDF]


Home page
EuropaceHome page
P. D. Bella, S. Riva, G. Fassini, M. Casella, C. Carbucicchio, N. Trevisi, M. Berti, F. Giraldi, and G. Maccabelli
Long-term follow-up after radiofrequency catheter ablation of atrial fibrillation: Role of the acute procedure outcome and of the clinical presentation
Europace, January 1, 2005; 7(2): 95 - 103.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
R. L. Page
Newly Diagnosed Atrial Fibrillation
N. Engl. J. Med., December 2, 2004; 351(23): 2408 - 2416.
[Full Text] [PDF]


Home page
ChestHome page
D. E. Singer, G. W. Albers, J. E. Dalen, A. S. Go, J. L. Halperin, and W. J. Manning
Antithrombotic Therapy in Atrial Fibrillation: The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy
Chest, September 1, 2004; 126(3_suppl): 429S - 456S.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
N. van Hemel
Quinidine rehabilitated and more lessons from the PAFAC and SOPAT anti-arrhythmic drug trials for the prevention of paroxysmal atrial fibrillation
Eur. Heart J., August 2, 2004; 25(16): 1371 - 1373.
[Full Text] [PDF]


Home page
Eur Heart JHome page
T. Fetsch, P. Bauer, R. Engberding, H. P. Koch, J. Lukl, T. Meinertz, M. Oeff, L. Seipel, H. J. Trappe, N. Treese, et al.
Prevention of atrial fibrillation after cardioversion: results of the PAFAC trial
Eur. Heart J., August 2, 2004; 25(16): 1385 - 1394.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
P. Ballo, D. Bernabo, and S. A. Faraguti
Heart rate is a predictor of success in the treatment of adults with symptomatic paroxysmal supraventricular tachycardia
Eur. Heart J., August 1, 2004; 25(15): 1310 - 1317.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
E. S. Kaufman and A. L. Waldo
The impact of asymptomatic atrial fibrillation
J. Am. Coll. Cardiol., January 7, 2004; 43(1): 53 - 54.
[Full Text] [PDF]


Home page
EuropaceHome page
L. Kristensen, J. C. Nielsen, P. T. Mortensen, A. K. Pedersen, and H. R. Andersen
Evaluation of pacemaker telemetry as a diagnostic feature for detecting atrial tachyarrhythmias in patients with sick sinus syndrome
Europace, January 1, 2004; 6(6): 580 - 585.
[Abstract] [Full Text] [PDF]


Home page
Asian Cardiovasc. Thorac. Ann.Home page
R. R Kasliwal, S. Mukesh, G. Manohar, N. Aggarwal, and A. Bhatia
Pharmacotherapy of Atrial Fibrillation
Asian Cardiovasc Thorac Ann, December 1, 2003; 11(4): 364 - 374.
[Abstract] [Full Text] [PDF]


Home page
JAMAHome page
D. E. Singer
A 60-Year-Old Woman With Atrial Fibrillation
JAMA, October 22, 2003; 290(16): 2182 - 2189.
[Full Text] [PDF]


Home page
J Am Coll CardiolHome page
K. A. Ellenbogen and M. A. Wood
Ablation of atrial fibrillation: awaiting the new paradigm
J. Am. Coll. Cardiol., July 16, 2003; 42(2): 198 - 200.
[Full Text] [PDF]


Home page
J Am Coll CardiolHome page
D. Darbar, K. J. Herron, J. D. Ballew, A. Jahangir, B. J. Gersh, W.-K. Shen, S. C. Hammill, D. L. Packer, and T. M. Olson
Familial atrial fibrillation is a genetically heterogeneous disorder
J. Am. Coll. Cardiol., June 18, 2003; 41(12): 2185 - 2192.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
M. Takami, M. Suzuki, K. Sugi, and T. Ikeda
Time course for resolution of left atrial appendage stunning after catheter ablation of chronic atrial flutter
J. Am. Coll. Cardiol., June 18, 2003; 41(12): 2207 - 2211.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
T. V. Glotzer, A. S. Hellkamp, J. Zimmerman, M. O. Sweeney, R. Yee, R. Marinchak, J. Cook, A. Paraschos, J. Love, G. Radoslovich, et al.
Atrial High Rate Episodes Detected by Pacemaker Diagnostics Predict Death and Stroke: Report of the Atrial Diagnostics Ancillary Study of the MOde Selection Trial (MOST)
Circulation, April 1, 2003; 107(12): 1614 - 1619.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
R. L. Page, T. W. Tilsch, S. J. Connolly, D. J. Schnell, S. R. Marcello, W. E. Wilkinson, E. L.C. Pritchett, and for the Azimilide Supraventricular Arrhythmia Prog
Asymptomatic or "Silent" Atrial Fibrillation: Frequency in Untreated Patients and Patients Receiving Azimilide
Circulation, March 4, 2003; 107(8): 1141 - 1145.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
R. H. Falk
Management of Atrial Fibrillation -- Radical Reform or Modest Modification?
N. Engl. J. Med., December 5, 2002; 347(23): 1883 - 1884.
[Full Text] [PDF]


Home page
QJMHome page
G.Y.H. Lip and F.L. L. S. Hee
Paroxysmal atrial fibrillation
QJM, December 1, 2001; 94(12): 665 - 678.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
P. B. Sparks and J. M. Kalman
Is atrial flutter a risk factor for stroke?
J. Am. Coll. Cardiol., September 1, 2001; 38(3): 785 - 788.
[Full Text] [PDF]


Home page
JAMAHome page
A. S. Go, E. M. Hylek, K. A. Phillips, Y. Chang, L. E. Henault, J. V. Selby, and D. E. Singer
Prevalence of Diagnosed Atrial Fibrillation in Adults: National Implications for Rhythm Management and Stroke Prevention: the AnTicoagulation and Risk Factors In Atrial Fibrillation (ATRIA) Study
JAMA, May 9, 2001; 285(18): 2370 - 2375.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
R. H. Falk
Atrial Fibrillation
N. Engl. J. Med., April 5, 2001; 344(14): 1067 - 1078.
[Full Text] [PDF]


Home page
J Am Coll CardiolHome page
S. S. Chugh, J. L. Blackshear, W.-K. Shen, S. C. Hammill, and B. J. Gersh
Epidemiology and natural history of atrial fibrillation: clinical implications
J. Am. Coll. Cardiol., February 1, 2001; 37(2): 371 - 378.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
R. L. Page, J. A. Reiffel, and M. E. Tavel
Asymptomatic Atrial Fibrillation : Problems of Management
Chest, February 1, 2001; 119(2): 628 - 631.
[Full Text] [PDF]


Home page
EuropaceHome page
K. J. Ward, J. E. Willett, C. Bucknall, J. S. Gill, and K. Kamalvand
Atrial arrhythmia suppression by atrial overdrive pacing: pacemaker Holter assessment
Europace, January 1, 2001; 3(2): 108 - 114.
[Abstract] [PDF]


Home page
J Am Coll CardiolHome page
E. L. C. Pritchett, R. L. Page, S. J. Connolly, S. R. Marcello, D. J. Schnell, W. E. Wilkinson, and the Azimilide Supraventricular Arrhythmia Program
Antiarrhythmic effects of azimilide in atrial fibrillation: efficacy and dose-response
J. Am. Coll. Cardiol., September 1, 2000; 36(3): 794 - 802.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
V. Kuhlkamp, A. Schirdewan, K. Stangl, M. Homberg, M. Ploch, and O. A. Beck
Use of metoprolol CR/XL to maintain sinus rhythm after conversion from persistent atrial fibrillation: A randomized, double-blind, placebo-controlled study
J. Am. Coll. Cardiol., July 1, 2000; 36(1): 139 - 146.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
R. L. Page
Beta-blockers for atrial fibrillation: must we consider asymptomatic arrhythmias?
J. Am. Coll. Cardiol., July 1, 2000; 36(1): 147 - 150.
[Full Text] [PDF]


Home page
EuropaceHome page
A. De Sisti, P. Attuel, S. Manot, P. Fiorello, F. Halimi, and J.-F. Leclercq
Electrophysiological determinants of atrial fibrillation in sinus node dysfunction despite atrial pacing
Europace, January 1, 2000; 2(4): 304 - 311.
[Abstract] [PDF]


Home page
Eur Heart JHome page
G.Y.H. Lip
Atrial fibrillation and mortality
Eur. Heart J., November 1, 1999; 20(21): 1525 - 1527.
[PDF]


Home page
Eur Heart JHome page
S Viskin, M Golovner, N Malov, R Fish, I Alroy, Y Vila, S Laniado, E Kaplinsky, and A Roth
Circadian variation of symptomatic paroxysmal atrial fibrillation. Data from almost 10000 episodes
Eur. Heart J., October 1, 1999; 20(19): 1429 - 1434.
[Abstract] [PDF]


Home page
J Am Coll CardiolHome page
M. H. Crawford, S. J. Bernstein, P. C. Deedwania, J. P. DiMarco, K. J. Ferrick, A. Garson Jr, L. A. Green, H. L. Greene, M. J. Silka, P. H. Stone, et al.
ACC/AHA guidelines for ambulatory electrocardiography: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the Guidelines for Ambulatory Electrocardiography) developed in collaboration with the North American Society for Pacing and Electrophysiology
J. Am. Coll. Cardiol., September 1, 1999; 34(3): 912 - 948.
[Full Text] [PDF]


Home page
CirculationHome page
S. Levy, M. Maarek, P. Coumel, L. Guize, J. Lekieffre, J.-L. Medvedowsky, and A. Sebaoun
Characterization of Different Subsets of Atrial Fibrillation in General Practice in France : The ALFA Study
Circulation, June 15, 1999; 99(23): 3028 - 3035.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
F. D. Murgatroyd, S. M. Gibson, X. Baiyan, S. O'Nunain, J. D. Poloniecki, D. E. Ward, M. Malik, and A. J. Camm
Double-Blind Placebo-Controlled Trial of Digoxin in Symptomatic Paroxysmal Atrial Fibrillation
Circulation, June 1, 1999; 99(21): 2765 - 2770.
[Abstract] [Full Text] [PDF]


Home page
ANN INTERN MEDHome page
P. J. Zimetbaum and M. E. Josephson
The Evolving Role of Ambulatory Arrhythmia Monitoring in General Clinical Practice
Ann Intern Med, May 18, 1999; 130(10): 848 - 856.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
F. Anselme, N. Saoudi, H. Poty, R. Douillet, and A. Cribier
Radiofrequency Catheter Ablation of Common Atrial Flutter : Significance of Palpitations and Quality-of-Life Evaluation in Patients With Proven Isthmus Block
Circulation, February 2, 1999; 99(4): 534 - 540.
[Abstract] [Full Text] [PDF]


Home page
EuropaceHome page
J.A. Goudevenos, J.N. Vakalis, V. Giogiakas, P. Lathridou, C. Katsouras, L.K. Michalis, and D.A. Sideris
An epidemiological study of symptomatic paroxysmal atrial fibrillation in northwest Greece
Europace, January 1, 1999; 1(4): 226 - 233.
[Abstract] [PDF]


Home page
CirculationHome page
M. Rosenqvist, T. Beyer, M. Block, K. den Dulk, J. Minten, and F. Lindemans
Adverse Events With Transvenous Implantable Cardioverter-Defibrillators : A Prospective Multicenter Study
Circulation, August 18, 1998; 98(7): 663 - 670.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
H. Paydak, J. G. Kall, M. C. Burke, D. Rubenstein, D. E. Kopp, R. J. Verdino, and D. J. Wilber
Atrial Fibrillation After Radiofrequency Ablation of Type I Atrial Flutter : Time to Onset, Determinants, and Clinical Course
Circulation, July 28, 1998; 98(4): 315 - 322.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
B. M. Psaty, T. A. Manolio, L. H. Kuller, R. A. Kronmal, M. Cushman, L. P. Fried, R. White, C. D. Furberg, and P. M. Rautaharju
Incidence of and Risk Factors for Atrial Fibrillation in Older Adults
Circulation, October 7, 1997; 96(7): 2455 - 2461.
[Abstract] [Full Text]


Home page
StrokeHome page
L. B. Goldstein, A. Farmer, and D. B. Matchar
Primary Care Physician–Reported Secondary and Tertiary Stroke Prevention Practices : A Comparison Between the United States and the United Kingdom
Stroke, April 1, 1997; 28(4): 746 - 751.
[Abstract] [Full Text]


Home page
CirculationHome page
E. N. Prystowsky, D. W. Benson Jr, V. Fuster, R. G. Hart, G. N. Kay, R. J. Myerburg, G. V. Naccarelli, and D. G. Wyse
Management of Patients With Atrial Fibrillation : A Statement for Healthcare Professionals From the Subcommittee on Electrocardiography and Electrophysiology, American Heart Association
Circulation, March 15, 1996; 93(6): 1262 - 1277.
[Full Text]


Home page
Arch Intern MedHome page
A. P. Aboaf and P. S. Wolf
Paroxysmal Atrial Fibrillation: A Common but Neglected Entity
Arch Intern Med, February 26, 1996; 156(4): 362 - 367.
[Abstract] [PDF]


Home page
CirculationHome page
F. Philippon, V. J. Plumb, A. E. Epstein, and G. N. Kay
The Risk of Atrial Fibrillation Following Radiofrequency Catheter Ablation of Atrial Flutter
Circulation, August 1, 1995; 92(3): 430 - 435.
[Abstract] [Full Text]